The contentious battle between LabMD and the Federal Trade Commission over the adequacy of the medical testing firm’s data security practices—the first such case to go to administrative trial—is set for...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: